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Selective profiling of N- and C-terminal
nucleotide-binding sites in a TRPM2 channel
Balázs Tóth1,2, Iordan Iordanov1,2, and László Csanády1,2
Transient receptor potential melastatin 2 (TRPM2) is a homotetrameric Ca2+-permeable cation channel important for the
immune response, body temperature regulation, and insulin secretion, and is activated by cytosolic Ca2+ and ADP ribose (ADPR).
ADPR binds to two distinct locations, formed by large N- and C-terminal cytosolic domains, respectively, of the channel
protein. In invertebrate TRPM2 channels, the C-terminal site is not required for channel activity but acts as an active ADPR
phosphohydrolase that cleaves the activating ligand. In vertebrate TRPM2 channels, the C-terminal site is catalytically inactive
but cooperates with the N-terminal site in channel activation. The precise functional contributions to channel gating and the
nucleotide selectivities of the two sites in various species have not yet been deciphered. For TRPM2 of the sea anemone
Nematostella vectensis (nvTRPM2), catalytic activity is solely attributable to the C-terminal site. Here, we show that nvTRPM2
channel gating properties remain unaltered upon deletion of the C-terminal domain, indicating that the N-terminal site is
single-handedly responsible for channel gating. Exploiting such functional independence of the N- and C-terminal sites, we
selectively measure their affinity profiles for a series of ADPR analogues, as reflected by apparent affinities for channel
activation and catalysis, respectively. Using site-directed mutagenesis, we confirm that the same N-terminal site observed in
vertebrate TRPM2 channels was already present in ancient cnidarians. Finally, by characterizing the functional effects of six
amino acid side chain truncations in the N-terminal site, we provide first insights into the mechanistic contributions of those
side chains to TRPM2 channel gating.
Introduction
Transient receptor potential melastatin 2 (TRPM2) is a member
of the melastatin subgroup of transient receptor potential family
ion channels (Nagamine et al., 1998). It is expressed in various
organs, including immune cells of phagocytic lineage (Sano
et al., 2001; Heiner et al., 2006), pancreatic β cells (Hara et al.,
2002; Togashi et al., 2006), and brain neurons (Perraud et al.,
2001; Nagamine et al., 1998). Physiological processes that have
been shown to require TRPM2 channel activity include immune
cell activation (Yamamoto et al., 2008), insulin secretion
(Uchida et al., 2011), and the central regulation of body tem-
perature by heat-sensitive neurons in the preoptic area of the
hypothalamus (Song et al., 2016). On the other hand, under
pathological conditions, activation of TRPM2 channels in re-
sponse to oxidative stress has been shown to underlie neuronal
cell death, such as postischemic brain injury or chronic neuro-
degenerative diseases (Hara et al., 2002; Kaneko et al., 2006;
Fonfria et al., 2005; Hermosura et al., 2008).
The TRPM2 protein is a homotetrameric Ca2+-permeable
cation channel. Its transmembrane domain, which forms the
channel pore, is flanked by large N- and C-terminal domains. Pore
opening is triggered by simultaneous binding of cytosolic ADP
ribose (ADPR; Perraud et al., 2001; Sano et al., 2001) and Ca2+
(McHugh et al., 2003; Csanády and Törocsik, 2009), but also re-
quires the presence of phosphatydyl-inositol-4-5-bisphosphate
(PIP2) in the inner membrane leaflet (Tóth and Csanády, 2012).
These basic functional features of TRPM2 channels have remained
unaltered since the first appearance of ancient TRPM2 channels in
choanoflagellates (Iordanov et al., 2019). The TRPM2 C-terminal
region comprises an ∼270 amino acid domain termed NUDT9-H
for its homology to the soluble mitochondrial enzyme NUDT9, a
Nudix-family ADPR pyrophosphatase that hydrolyses ADPR into
AMP and ribose-5-phosphate (r-5-P; Perraud et al., 2001). The
NUDT9-H domain of human TRPM2 (hsTRPM2) is catalytically
inactive (Iordanov et al., 2016), but TRPM2 channels from two
invertebrate species, the choanoflagellate Salpingoeca rosetta
(srTRPM2) and the cnidarian Nematostella vectensis (nvTRPM2),
were shown to be active chanzymes that cleave ADPR. Such
functional dichotomy is explained by the presence of an intact
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“Nudix-box” sequence motif in the NUDT9-H domains of inver-
tebrate TRPM2 channels, but by the appearance of mutations in
key Nudix-box positions in vertebrates (Kühn et al., 2016;
Iordanov et al., 2019). Because at the same evolutionary time pore
mutations that cause irreversible inactivation also appeared, it
was suggested that for invertebrate channels ligand cleavage by
the NUDT9-H domain served as an inactivationmechanismwhich
was replaced by pore inactivation in vertebrates (Iordanov et al.,
2019). Surprisingly, nvTRPM2 channels were shown to remain
activatable by ADPR following deletion of the nvNUDT9-H do-
main, suggesting the presence of a second ADPR-binding site
outside this domain (Kühn et al., 2016).
Recently, high-resolution structures of TRPM2 channel pro-
teins from several species, in various conformations, have been
solved by cryo-electron microscopy. The Ca2+-bound structure
of the nvTRPM2 protein (Protein Data Bank [PDB] accession no.
6CO7; Zhang et al., 2018), obtained in the absence of ADPR, re-
vealed a three-tiered architecture, conserved among TRPM-
family channels (Guo et al., 2017; Autzen et al., 2018; Winkler
et al., 2017; Yin et al., 2018), consisting of a transmembrane layer
and two cytosolic layers. In this structure, the location of the
activating Ca2+-binding site could be identified within the
transmembrane region, but the nvNUDT9-H domain was not
resolved, suggesting that it is flexibly attached to the rest of the
protein. In contrast, in structures of zebrafish (Danio rerio)
TRPM2 (drTRPM2; PDB accession nos. 6DRK and 6DRJ [Huang
et al., 2018]; 6PKV, 6PKW, 6D73, and 6PKX [Yin et al., 2019]) and
hsTRPM2 (PDB accession numbers 6MIX, 6MIZ, and 6MJ2
[Wang et al., 2018]; 6PUO, 6PUR, 6PUS, and 6PUU [Huang
et al., 2019]), the NUDT9-H domains are seen to form an addi-
tional cytosolic layer that undergoes pronounced conformational
changes in response to ADPR binding to the channel protein.
Whereas ADPR bound at the NUDT9-H domain has been re-
solved so far only for hsTRPM2 (6PUS; Huang et al., 2019), a
molecule of ADPR bound in a cleft of the MHR1/2 region of the
large N-terminal domain was clearly resolved in ADPR-bound
structures of both drTRPM2 (PDB accession no. 6DRJ; Huang
et al., 2018) and hsTRPM2 (PDB accession no. 6PUS; Huang
et al., 2019). Mutations of conserved residues in this “N-
terminal–binding site” abrogated channel function, providing
evidence for its involvement in channel activation (Huang et al.,
2018, 2019; but cf. Wang et al., 2018). On the other hand, unlike
for nvTRPM2 (Kühn et al., 2016), for vertebrate TRPM2 chan-
nels, the presence of an intact NUDT9-H domain also seemed
indispensable for channel function, as mutations in (Yu et al.,
2017; Huang et al., 2019) or deletion of (Wang et al., 2018; Huang
et al., 2019) the NUDT9-H domain abrogated channel activity for
both drTRPM2 and hsTRPM2. The current understanding is that
in ancient (invertebrate) TRPM2 channels, the N-terminal site
served to activate the channel, whereas the main task of the
C-terminal site was to clear away the activating ligand. Over the
course of evolution, the C-terminal site lost its enzymatic ac-
tivity but gained more functional relevance for channel gating.
However, the precise contributions of the N- and C-terminal
sites to TRPM2 channel function in various species are still
not entirely clear, and the nucleotide-binding preferences of the
two sites have not yet been sorted out.
The aim of the present study was to exploit the enzymatic
activity of invertebrate NUDT9-H domains for selective deter-
mination of nucleotide-binding affinities at the two sites in
nvTRPM2. A further aim was to confirm whether the ADPR-
binding site responsible for activation of the ancient nvTRPM2
channel is identical to the N-terminal site identified in the
vertebrate channel structures. Finally, we quantitatively as-
sessed the importance for channel gating of conserved residues
seen to interact with ADPR in the N-terminal site.
Materials and methods
Molecular biology
For expression in Xenopus laevis oocytes, the full-length
nvTRPM2 gene was subcloned into the pGEMHE vector as
described previously (Zhang et al., 2018). Replacement of the
codons encoding amino acids 1208–1209 or 1242–1243, respec-
tively, by double stop codons to generate 1208STOP and
1242STOP constructs, and point mutations targeting the
N-terminal site, were implemented using the QuickChange II
XL mutagenesis kit (Agilent Technologies). To generate the
1208CUT deletion construct, the QuickChange kit was used to
introduce an XbaI restriction site into nvTRPM2(1208STOP)-
pGEMHE following its double stop codon at positions
1208–1209 (forward primer 59-TTAAACAGGGTGTTAGATTGA
TAGTCTAGAACTCGGGCTCACGCC-39 and reverse primer 59-
GGCGTGAGCCCGAGTTCTAGACTATCAATCTAACACCCTGTT
TAA-39). Digestion of the resulting plasmid by XbaI (New
England Biolabs) excised the DNA fragment between the en-
gineered XbaI site and a second XbaI site present in the
pGEMHE multiple cloning site downstream of the insert. The
resulting two fragments (∼1.0 kb and ∼6.7 kb) were separated
by agarose gel electrophoresis. The 6.7-kb fragment was ex-
cised from the gel, purified (QIAquick Gel Extraction Kit; Qia-
gen), and ligated using T4 ligase (New England Biolabs). All
constructs were verified by full insert sequencing (LGC Ge-
nomics GmbH). cDNA was linearized with NheI, transcribed
in vitro using T7 polymerase (mMessage mMachine T7 Kit;
Thermo Fisher), and cRNA stored at −80°C. For bacterial ex-
pression of nvNUDT9-H, the DNA sequence encoding nvTRPM2
residues 1271–1551, with added C-terminal Twin-Strep-tag
(General Biosystems), was incorporated into the pJ411 vector
as described previously (Iordanov et al., 2019).
Protein expression and purification
The isolated nvNUDT9-H domain was expressed in Escherichia
coli BL21 (DE3) and purified as described previously (Iordanov
et al., 2019). In brief, bacterial cultures induced with 0.1 mM
isopropyl-β-D-1-thio-galactopyranoside overnight at 25°C were
lysed by sonication, centrifuged (15,000×g for 30 min at 4°C),
and the protein purified from the supernatant using Strep-
Tactin affinity chromatography (IBA GmbH), followed by gel
filtration (Superdex 200 10/300 GL; GEHealthcare). The affinity
tag was not removed. Protein purity was evaluated by SDS-
PAGE and protein identity confirmed by the band position and
the main peak position on the gel filtration profile. Protein yield,
determined spectrophotometrically using a theoretical molar
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extinction coefficient (ε0 = 58,320 M−1 cm−1 at 280 nm), was
∼5 mg/liter of culture. The purified protein was flash frozen in
liquid nitrogen and stored at −20°C until use.
Enzymatic activity assay
ADPR pyrophosphatase activity of purified nvNUDT9-H was
quantified through colorimetric detection of Pi liberated from
the ADPR cleavage products AMP and r-5-P by coapplied alka-
line phosphatase (AP), as described previously (Iordanov et al.,
2019). In brief, 150-µl volumes of reaction buffer (50 mM
Tris, pH 8.5, and 16 mM MgCl2) containing 0.5 nM purified
nvNUDT9-H protein, 2–3 U bovine AP, and 5–160 µM of the tested
ADPR analogue (ADPR, 29-deoxy-ADPR [dADPR], 8-Br-ADPR [Br-
ADPR], or 1,N6-ethenoadenosine-59-O-diphosphoribose [ε-ADPR])
were incubated for 4–5 min at room temperature. The reactions
were stopped and the liberated Pi visualized by adding 850 µl
coloring solution (6:1 vol/vol ratio mixture of 0.42% ammonium
molybdate tetrahydrate in 1N H2SO4 and 10% L-ascorbic acid)
followed by incubation for 20 min at 45°C. Absorption at 820 nm
was measured (NanoPhotometer P300; Implen GmbH) and com-
pared with that of a standard curve (1–2,000 µM KH2PO4). All
reagents were from Sigma-Aldrich.
The analogue ADPR-29-phosphate (ADPRP) contains an ad-
ditional phosphate group at the 29 position and is cleaved into
r-5-P plus adenosine 29,59-diphosphate (AMP-29-P) by nvNUDT9-H.
However, the 29-phosphate is always accessible to the AP, re-
gardless of whether the pyrophosphate bond of the nucleotide
has been hydrolyzed or not. To assess nvNUDT9-H hydrolytic
activity on ADPRP, 150-µl volumes of reaction buffer (50 mM
Tris, pH 8.5, and 1 mM MgCl2) containing 1 nM purified
nvNUDT9-H and 5–160 µM ADPRP were incubated for 5 min at
room temperature. The hydrolytic reaction was then stopped
by addition of 1.5 mM EDTA, which chelates the Mg2+ necessary
for nvNUDT9-H activity (Iordanov et al., 2019). Subsequently,
2–3 U bovine AP was added for 10 min at room temperature to
liberate all the accessible phosphates, which include all the 29-
phosphates (from unhydrolyzed ADPR-29-P plus the hydrolysis
product AMP-29-P), in addition to the phosphates that had
become accessible as a consequence of ADPRP hydrolysis (59-
phosphate of AMP-29-P plus 5-phosphate of r-5-P). Total re-
leased free phosphate was quantitated as for the other ADPR
analogues. A set of identically treated samples, containing
5–160 µM ADPRP but no nvNUDT9-H, was used to establish
“background” phosphate, originating from the 29-phosphate of
ADPRP, which was then subtracted from the total phosphate
released in the respective nvNUDT9-H–containing samples.
The molecular turnover rate (kcat) of nvNUDT9-H toward its
substrates was calculated from the reaction rates at the highest
(saturating) substrate concentration of the dose–response
curves; not more than 10% of the initial substrate was hydro-
lyzed in this condition. All assays were performed at least in
triplicate, and data are displayed as mean ± SEM.
Functional expression of nvTRPM2 constructs in
Xenopus oocytes
Xenopus oocytes were isolated, collagenase digested, and in-
jected with 0.1–10 ng cRNA encoding WT or mutant nvTRPM2,
nvTRPM2(1208STOP), nvTRPM2(1208CUT), ornvTRPM2(1242STOP)
as described previously (Zhang et al., 2018). Injected oocytes were
stored at 18°C, and recordings were done 1–3 d after injection.
Electrophysiology
Excised inside-out patch-clamp recording of nvTRPM2 currents
was done as described previously (Zhang et al., 2018). Pipette
(extracellular) solution contained (in mM) 140 Na-gluconate,
2 Mg-gluconate2, 10 HEPES (pH 7.4 with NaOH); a 140 mM
NaCl–based solution for the pipette electrode was carefully
layered on top (Csanády and Törocsik, 2009). In some experi-
ments (e.g., to measure intracellular [Ca2+] dependence of
channel activity), 1 mM EGTA was also included in the pipette
solution. Bath (cytosolic) solution contained (in mM) 140 Na-
gluconate, 2 Mg-gluconate2, 10 HEPES, and 1 EGTA (pH 7.1
with NaOH) plus 0–760 µM Ca-gluconate2 to obtain “zero” (∼1
nM) or 0.03–1 µM Ca2+. To obtain 1.75–125 µM free [Ca2+], EGTA
was omitted from the bath and 10 µM to 1 mM Ca-gluconate2
was added (Csanády and Törocsik, 2009). The bath electrode (in
3 M KCl) was connected to the cytosolic solution through a
KCl–agar bridge. Recordings were obtained at 25°C at a mem-
brane potential of −20 mV under continuous superfusion of the
cytosolic patch surface. The composition of the cytosolic solution
could be exchanged using electronic valves (ALA-VM8; ALA
Scientific Instruments); the exchange time constant was <50ms.
Currents were recorded at a bandwidth of 2 kHz (Axopatch
200B; Molecular Devices), digitized at 10 kHz (Digidata 1440A;
Molecular Devices), and saved to disk (Pclamp10; Molecular
Devices). Na2-ADPR was obtained from Sigma-Aldrich, and so-
dium salts of dADPR, ADPRP, Br-ADPR, and ε-ADPR were ob-
tained from Biolog Life Science Institute. Nucleotides were
diluted into the bath solution from 10–200 mM aqueous stocks,
pH adjusted to 7.1 using NaOH. Dioctanoyl PIP2 sodium salt
(Cayman Chemical) was diluted into the bath solution from a
2.5 mM aqueous stock.
Analysis of current recordings
To obtain dose–response curves for nucleotides (Figs. 1, 2, 5, and
6) or Ca2+ (Fig. 7), fractional currents were calculated by di-
viding mean current in a test segment by mean current in sat-
urating nucleotide plus saturating Ca2+, in bracketing segments
of recording from the same patch. To estimate unitary current
amplitudes (Fig. S2 B), all-points histograms, generated from
recordings with well resolved unitary transitions after digital
filtering at 200 Hz, were fitted by multiple Gaussian functions.
Statistics
Data are displayed as mean ± SEM, with the number of ex-
periments indicated in the figure legends. For the electrophys-
iological recordings, n represents the number of patches (n =
3–44). For the enzymatic activity assays, n = 3–8 from inde-
pendent technical replicates.
Online supplemental material
Fig. S1 shows that deletion of the nvNUDT9-H coding sequence
results in channels indistinguishable from nvTRPM2(1208STOP).
Fig. S2 shows the correction for pore block by cytosolic Ca2+
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employed for extracting Ca2+ effects on open probability (Po) for
WT nvTRPM2 and MHR1/2 domain mutants.
Results
Apparent affinity for nvTRPM2 channel activation by ADPR is
little affected by deletion of the nvNUDT9-H domain
Deletion of the NUDT9-H domain from nvTRPM2 results in
channels that remain activatable by ADPR (Kühn et al., 2016),
but to what extent such truncation affects channel gating
properties remains to be established. To quantitatively assess
the potency (half-maximal effective concentration; EC50) for
channel activation of nvTRPM2 channels lacking the entire
NUDT9-H domain, we reproduced the reported truncation
mutant by introducing a double stop codon following amino acid
position 1207 (1208STOP) and compared the functional proper-
ties of such channels to those of full-length nvTRPM2 by
recordingmacroscopic inwardNa+ currents at −20mV in inside-
out patches excised from Xenopus oocytes preinjected with the
corresponding cRNA (Fig. 1). Just as for full-length nvTRPM2
(Fig. 1 A), channels truncated at position 1208 (Fig. 1 B) gener-
ated macroscopic currents that required coapplication of cyto-
solic Ca2+ (black bars) and ADPR (gray bars) for activation,
although expression levels were markedly reduced for the
truncated construct. To obtain normalized dose–response curves
(Fig. 1 D; red and dark blue symbols), steady-state currents in
various test [ADPR]were normalized to the currents observed in
the same patches upon bracketing exposures to saturating
ADPR. From fits to the Hill equation (Fig. 1 D; red and dark
blue lines), the EC50 for channel activation by ADPR for
nvTRPM2(1208STOP) remained within twofold of that of the
full-length channel (4.2 ± 0.6 µM vs. 2.3 ± 0.2 µM). Truncation
at position 1208 removes, in addition to the nvNUDT9-H do-
main, the second part of a predicted coiled-coil region (Mei
et al., 2006), which forms a second coiled-coil helix in some
drTRPM2 structures (Yin et al., 2019). To generate channels
that lack the nvNUDT9-H domain but retain the entire pre-
dicted coiled-coil region, we also designed a somewhat longer
truncation construct by inserting a double stop codon after
amino acid position 1241. The resulting truncation mutant
(1242STOP) behaved very similarly to the 1208STOP construct
(Fig. 1, C and D, yellow symbols).
Although our truncation constructs were terminated using
double stop codons, a translational readthrough can in principle
not be excluded. We therefore also generated (see Materials and
methods) an nvNUDT9-H deletion construct (1208CUT) by
eliminating from our expression plasmid the entire DNA se-
quence encoding for the nvNUDT9-H domain (amino acids
1208–1551). Xenopus oocytes preinjected with cRNA transcribed
from this plasmid developed ADPR- and Ca2+-dependent cation
currents that were indistinguishable from those of the 1208STOP
construct (Fig. S1 A), including the EC50 for activation by ADPR
(4.6 ± 0.3 µM; Fig. S1 B).
Nucleotide affinity profiles for channel activation and ligand
hydrolysis in nvTRPM2 are markedly different
For hsTRPM2 it is very difficult to functionally dissect the
ligand-binding affinities of the N- and C-terminal sites, as the
relative contribution to channel activity (the only functional
readout) of ligand binding at either site is unclear (Huang et al.,
2018; Wang et al., 2018). In contrast, the intact ADPR depen-
dence of gating of NUDT9-H–deleted nvTRPM2 channels (Fig. 1)
indicates that in nvTRPM2, unlike in vertebrate TRPM2, the
activating ADPR-binding site is not only located outside the
nvNUDT9-H domain (Kühn et al., 2016) but also single-handedly
responsible for channel activation. On the other hand, we have
previously shown that the catalytic activity of nvTRPM2 is solely
attributable to the nvNUDT9-H domain, which in its isolated
form recapitulates the catalytic properties of the full-length
protein (Iordanov et al., 2019). Such functional independence
Figure 1. ADPR affinity for channel activation is intact for
nvTRPM2 channels lacking the NUDT9-H domain. (A–C)
Macroscopic inward Na+ currents at −20 mV membrane po-
tential activated by cytosolic exposure to various concen-
trations of ADPR (gray bars) plus 125 µM Ca2+ (black bars)
recorded from inside-out patches excised from Xenopus oocytes
preinjected with cRNA encoding full-length (A), 1208STOP (B),
or 1242STOP (C) nvTRPM2. (D) Steady-state currents in the
presence of test [ADPR], normalized to the mean of the currents
during bracketing exposures of the same patch to saturating
(100–1,000 µM) ADPR, plotted as a function of [ADPR] for full-
length (dark blue symbols), 1208STOP (red symbols), and
1242STOP (yellow symbols) nvTRPM2. Data represent mean ±
SEM from 3 to 32 independent experiments. Fits to the Hill
equation (colored lines) yielded fit parameters of EC50 = 2.3 ±
0.2 µM, nH = 1.4 ± 0.1 for full-length; EC50 = 4.2 ± 0.6 µM, nH =
1.2 ± 0.2 for 1208STOP; and EC50 = 7.4 ± 0.7 µM, nH = 1.3 ± 0.1
for 1242STOP nvTRPM2.
Tóth et al. Journal of General Physiology 4 of 12
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of the two sites offers a unique opportunity to selectively mea-
sure the binding affinity of a particular ligand to the nvNUDT9-
H domain, as reported by the Km for its hydrolysis (Iordanov
et al., 2019), and to the activating site, as reported by the EC50 for
channel activation (Fig. 1 D).
Several ADPR analogues have been identified in the past as
alternative ligands or inhibitors of hsTRPM2 (Moreau et al.,
2013; Tóth et al., 2015; Iordanov et al., 2016; Luo et al., 2018a;
Fliegert et al., 2017; Baszczyňski et al., 2019). Among identi-
fied hsTRPM2 agonists ADPRP acts as a low-affinity partial
agonist (Tóth et al., 2015), whereas dADPR was described as a
“super-agonist” because it activated larger maximal whole-
cell hsTRPM2 currents compared with ADPR (Fliegert et al.,
2017). Among reported antagonists, Br-ADPR was the first
identified specific hsTRPM2 inhibitor (Moreau et al., 2013),
whereas ε-ADPR acts on hsTRPM2 as a low-affinity antagonist
(Iordanov et al., 2016). For the above ADPR analogues vastly
different apparent affinities, ranging from ∼1 µM to ∼300 µM,
have been reported.
To characterize the potencies and efficacies of various nu-
cleotides for nvTRPM2 channel activation, we recorded macro-
scopic inside-out patch currents of WT nvTRPM2 evoked by
cytosolic exposure to dADPR (Fig. 2 A, purple bars), ADPRP
(Fig. 2 B, red bars), or Br-ADPR (Fig. 2 C, green bars) in the
presence of 125 µM cytosolic Ca2+ (black bars). Steady-state
currents elicited by increasing concentrations of these nucleo-
tides were normalized to the currents observed in the same
patches upon bracketing exposures to saturating ADPR (Fig. 2,
A–C, dark blue bars) and plotted as a function of nucleotide
concentration (Fig. 2 D); normalized dose–response curves
(colored symbols) were fitted by the Hill equation (colored
lines). The obtained dose–response curves reveal largely dif-
ferent EC50 values for the various nucleotides toward nvTRPM2
channel activation (Table 1, center column) and also some no-
table differences relative to earlier reports on hsTRPM2. In
particular, for nvTRPM2, Br-ADPR (Fig. 2 D, green) is a low-
affinity (EC50 ∼30 µM) partial agonist with a maximal efficacy
of ∼0.3 relative to ADPR, whereas dADPR (Fig. 2 D, purple; EC50
∼2.7 µM) is similarly efficacious and potent as ADPR (Fig. 2 D,
dark blue, EC50 ∼2.3 µM). Intriguingly, ADPRP (Fig. 2 D, red),
which is a low-affinity partial agonist of hsTRPM2 (Tóth
et al., 2015), is not only a full agonist of nvTRPM2 but also dis-
plays a higher affinity (EC50 ∼0.4 µM) than ADPR, consistent
Figure 2. Apparent affinities of ADPR analogues for nvTRPM2 N- and
C-terminal sites. (A–C) Macroscopic nvTRPM2 currents activated by cyto-
solic exposure to either 100 µM ADPR (dark blue bars) or various concen-
trations of dADPR (A; purple bars), ADPRP (B; red bars), or Br-ADPR (C; green
bars) in the presence of 125 µM Ca2+ (black bars). (D) Steady-state currents in
the presence of various test nucleotide concentrations, normalized to the
mean of the currents during bracketing exposures of the same patch to 100
µM ADPR, plotted as a function of nucleotide concentration for ADPR (dark
blue symbols, replotted from Fig. 1 D), dADPR (purple symbols), ADPRP (red
symbols), and Br-ADPR (green symbols). Data represent mean ± SEM from 3
to 32 independent experiments. EC50 values, obtained from fits to the Hill
equation (colored lines), are summarized in Table 1 (center column). Maximal
fractional activation was 1.1 ± 0.04 for dADPR, 1.06 ± 0.03 for ADPRP, and
0.29 ± 0.01 for Br-ADPR; Hill coefficients were nH = 1.3 ± 0.2 for dADPR, nH =
2.1 ± 0.4 for ADPRP, and nH = 1.6 ± 0.2 for Br-ADPR. (E) Macroscopic
nvTRPM2 currents in 3.2 or 100 µM ADPR (dark blue bars), in 200 µM ε-ADPR
(first yellow bar), and in 3.2 µM ADPR + 200 µM ε-ADPR (second yellow bar),
all in the presence of 125 µM Ca2+ (black bars). (F) Normalized ADPR
dose–response curves of nvTRPM2 in the absence of ε-ADPR (blue-white
symbols) and in the presence of a fixed concentration of either 100 µM (blue-
gray symbols) or 200 µM (blue-yellow symbols) ε-ADPR. For all ADPR con-
centrations, currents with or without ε-ADPR were obtained within the same
patches and normalized to the mean of the currents during bracketing ex-
posures to 100 µM ADPR alone. Data represent mean ± SEM, from 4 to 18
independent experiments. The three dose–response plots were simulta-
neously fitted (dark blue dashed, dotted, and solid curves) to the equation
I/I100ADPR = Îmax × [ADPR]n/(EC50 × (1 + [ε-ADPR]/IC50)n + [ADPR]n), with Îmax,
EC50, n, and IC50 as free parameters. This global fit returned parameter es-
timates Îmax = 1.0 ± 0.0, EC50 = 1.6 ± 0.2 µM (for ADPR), n = 1.5 ± 0.1, and IC50 =
269 ± 91 µM (for ε-ADPR). (G) Rates of nucleotide hydrolysis by the isolated,
purified nvNUDT9-H domain as a function of substrate concentration, using
ADPR (dark blue symbols; replotted from Iordanov et al., 2019), dADPR
(purple symbols), ADPRP (red symbols), Br-ADPR (green symbols), or
ε-ADPR (yellow symbols) as the substrate. Reaction rates (mean ± SEM
from three to eight independent experiments) were normalized to those
observed at the highest substrate concentration. Solid colored lines repre-
sent fits to the Michaelis–Menten equation, and obtained Km values are
plotted in Table 1 (left column). (H) Molecular turnover numbers (kcat) of
isolated, purified nvNUDT9-H for the five substrates in G, measured at
saturating substrate concentrations. Data represent mean ± SEM from three
to eight independent experiments.
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with an earlier report (Kühn et al., 2016). In the presence of
125 µM cytosolic Ca2+, exposure to 200 µM ε-ADPR alone in-
duced only tiny currents (Fig. 2 E, first yellow bar), but coap-
plication of 200 µM ε-ADPR reduced by ∼25% the currents
elicited by 3.2 µM ADPR (Fig. 2 E, second yellow bar), signaling a
dose-dependent rightward shift in the ADPR dose–response
curve in the presence of the analogue (Fig. 2 F). This identifies
ε-ADPR as a low-affinity antagonist for nvTRPM2 (half-maximal
inhibitory concentration; IC50 ∼270 µM), just as for hsTRPM2.
In contrast to the variable efficacies and potencies for
nvTRPM2 channel activation, the isolated nvNUDT9-H domain
showed little selectivity among the same ligands. All five ana-
logues were efficiently hydrolyzed by nvNUDT9-H, with kcat
values ranging between ∼11 s−1 and ∼48 s−1 (Fig. 2 H). Moreover,
the apparent affinities of the five analogues for binding to
nvNUDT9-H, as reported by their Km values, remainedwithin an
approximately sixfold range (Fig. 2 G and Table 1, left).
Mutation of a subset of side chains in the predicted N-terminal
site reduces maximal Po of nvTRPM2 channels
In vertebrate TRPM2 structures (e.g., PDB accession nos. 6DRJ
and 6PUS), the N-terminal ADPR-binding site (Fig. 3 A, bound
ADPR shown in orange spacefill) is formed by multiple non-
contiguous peptide segments that span ∼185 residues in primary
sequence (Fig. 3 D). Several key backbone and side-chain in-
teractions with the bound nucleotide appear identical between
drTRPM2 and hsTRPM2 and involve amino acids that are also
conserved in nvTRPM2 (Fig. 3 D, red; Huang et al., 2018). To
address the contribution to ADPR binding of the corresponding
region in nvTRPM2, we targeted six side chains for mutagenesis
(Fig. 3 B). In drTRPM2 the T186 and Y271 side chains form a
hydrogen bond and a pi–pi stacking interaction, respectively,
with the adenine base, the R334 and T312 side chains form polar
contacts with the ADPR α- and β-phosphates, respectively, and
the T150 and R278 side chains form hydrogen bonds with the
terminal ribose (Fig. 3 B, black labels and black dotted lines). The
corresponding residues in nvTRPM2 are T179, Y264, R329, T307,
T143, and R271 (Fig. 3, B and C, red labels).
We mutated each of the six target residues, one at a time, to
alanine and studied the resulting mutant nvTRPM2 channels in
inside-out patch-clamp experiments (Fig. 4). Just as for WT
nvTRPM2, in the presence of Ca2+ (125 µM), large macroscopic
currents could be activated for each of the six mutants by cy-
tosolic exposure to very high concentrations (3.2 mM) of ADPR
(Fig. 4, A–G, gray bars). Under such conditions, Po of WT
channels is close to unity (Iordanov et al., 2019), and addition of
exogenous short-chain PIP2 causes only marginal additional
stimulation (Zhang et al., 2018; Fig. 4 A). Similarly small frac-
tional stimulation by 2.5 and 25 µM PIP2 was also observed for
the T143A and T307A mutants (Fig. 4, B, D, and H, dark blue and
red symbols), suggesting that their Pos are also close to unity. In
contrast, macroscopic currents were stimulated by approxi-
mately twofold for R271A (Fig. 4, C and H, green symbols), ap-
proximately sixfold for R329A (Fig., 4 E and H, purple symbols),
∼40-fold for Y264A (Fig. 4, G and H, yellow symbols), and ∼80-
fold for T179A (Fig. 4, F and H, light blue symbols) upon expo-
sure to 25 µM PIP2. These robust PIP2 responses indicate that
channel Po in 125 µM Ca2+ + 3.2 mM ADPR must be substantially
reduced for R271A and R329A and vanishingly small for T179A,
and Y264A nvTRPM2 channels.
Mutation of several side chains in the predicted N-terminal
site dramatically increases EC50 for nvTRPM2 channel
activation by ADPR analogues
We next studied for all six mutants the apparent affinities for
channel activation by ADPR by exposing the cytosolic faces of
inside-out macropatches to a series of ADPR concentrations,
bracketed by exposures to a high concentration (0.32 or 3.2 mM)
of ADPR (Fig. 5, A–G). To enhance channel currents for the low-
Po mutants, these experiments were performed in the main-
tained presence of 125 µM Ca2+ plus 2.5 µM PIP2 (Fig. 5, A–G,
black bars). Fractional currents in the presence of the test ADPR
concentrations, normalized to the mean of the currents in the
bracketing high-ADPR segments, were plotted as a function of
[ADPR] (Fig. 5 H, colored symbols) and fitted to the Hill equation
(Fig. 5 H, colored lines). Of note, for WT nvTRPM2, inclusion of
2.5 µM PIP2 only minimally affected the EC50 for ADPR activa-
tion (compare Fig. 5 H, black symbols, and Fig. 1 D, dark blue
symbols). Interestingly, the R271A mutation (Fig. 5 C) caused a
slight leftward shift of the ADPR dose–response curve, de-
creasing the EC50 for channel activation by approximately
twofold, from 1.5 ± 0.1 µM (WT) to 0.62 ± 0.05 µM (R271A;
Fig. 5 H, green vs. black). In contrast, all other mutations caused
pronounced rightward shifts in the ADPR dose–response curve
(Fig. 5 H, colored vs. black), increasing the EC50 for channel
activation by approximately fourfold (T143A; Fig. 5, B and H,
dark blue), ∼10-fold (T179A; Fig. 5, F and H, light blue), ∼20-fold
(T307A; Fig. 5, D and H, red), and >1,000-fold (R329A and









ADPR 4.1 ± 0.6 2.3 ± 0.2 1.4 ± 0.1 (Tóth
et al., 2015)
dADPR 5.7 ± 0.6 2.7 ± 0.3 n.d.
Br-ADPR 3.4 ± 0.4 31.9 ± 2.8 n.d.





14.9 ± 4.0 0.42 ± 0.04 13 ± 1 (Tóth et al.,
2015)
Km values of the isolated nvNUDT9-H domain for hydrolysis of various ADPR
analogues (left column), and EC50 for nvTRPM2 channel activation (for
ε-ADPR IC50 for inhibition) by the same nucleotides in the presence of 125
µM cytosolic Ca2+ (center column). Data represent mean ± SEM obtained
from least-squares fits of the Michaelis–Menten (Km) or Hill (EC50) equation
to the respective dose–response curves. Right column lists published EC50
(IC50) values for activation (inhibition) of hsTRPM2 by ADPR analogues; to
allow meaningful comparison, only reports that were obtained in inside-out
patches, in the presence of saturating cytosolic Ca2+, are listed. n.d., not
determined.
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Y264A; Fig. 5, E, G, and H, purple and yellow), as expected for
truncations of side chains that are directly involved in ADPR
binding.
The currents of the lowest-affinity mutants R329A and
Y264A failed to saturate even in 3.2 mM ADPR (Fig. 5 H, purple
and yellow), rendering estimation of EC50 values uncertain.
Because ADPRP is approximately fivefold more potent compared
with ADPR for activating WT nvTRPM2 (Fig. 2 D), we also ob-
tained dose–response relationships for all six mutants using
ADPRP as the activating ligand. Indeed, in a set of analogous
experiments (Fig. 6, A–G), performed again in the presence of
125 µM Ca2+ plus 2.5 µM PIP2, we could obtain complete ADPRP
dose–response curves for all mutants (Fig. 6 H). Apart from
providing more reliable EC50 estimates for the low-affinity
mutants, the ADPRP dose–response pattern recapitulated that
observed for ADPR; the obtained EC50 values spanned more than
three orders of magnitude, with similar fractional changes
caused by each particular mutation (compare Fig. 6 H to
Fig. 5 H).
None of the mutations in the predicted N-terminal site
dramatically affects EC50 for channel activation by Ca2+
A subset of the region comprising the N-terminal site was
identified in a previous study to form a tandem EF hand for Ca2+
binding (Luo et al., 2018b). To assess a potential effect of our
mutations on the sensitivity toward Ca2+ activation, we studied
for WT nvTRPM2 and all six mutants the apparent affinities for
activation by Ca2+ (Fig. 7, A–G) in the maintained presence of
saturating ADPRP plus 2.5 µM PIP2 (black bars). Fractional
currents in the presence of test Ca2+ concentrations were nor-
malized to the mean of the currents observed in bracketing
segments in 125 µM Ca2+ and corrected for a small reduction in
Figure 3. Amino acid side chains interacting with ADPR bound in the MHR1/2 domain. (A) Cartoon representation of drTRPM2 structure solved in the
presence of ADPR+Ca2+ (PDB accession no. 6DRJ). One subunit is highlighted in light blue, except for the NUDT9-H domain, which is shown in dark blue. ADPR
is represented in orange spacefill and Ca2+ as purple sphere. (B) Stick representation of ADPR bound in the MHR1/2 domain of drTRPM2 and six amino acid side
chains (black labels) in contact with the nucleotide. Dotted black lines represent polar contacts identified by PyMOL. Red labels in parentheses refer to
corresponding nvTRPM2 residues. (C) Schematic representation of ADPR and expected interacting residues in the MHR1/2 domain of nvTRPM2. (D) Sequence
alignment of nvTRPM2, drTRPM2, and hsTRPM2 peptide segments involved in ADPR coordination in the N-terminal site. Residues targeted for mutagenesis are
highlighted in red, with nvTRPM2 sequence numbering shown on top.
Tóth et al. Journal of General Physiology 7 of 12
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unitary current amplitudes caused by 125 µM cytosolic Ca2+ (Fig.
S2; cf. Zhang et al., 2018). The resulting normalized Pos were
plotted against Ca2+ concentration (Fig. 7 H, symbols) and fitted
by the Hill equation (Fig. 7 H, solid lines). Under such conditions,
the EC50 for Ca2+ was 0.88 ± 0.07 µM forWT nvTRPM2 (Fig. 7 H,
black) and remained within approximately twofold of the WT
value for all six N-terminal site mutants (Fig. 7 H, colors).
Discussion
In vertebrate TRPM2 channels, the NUDT9-H domain is cata-
lytically inactive, and both the N-terminal (Huang et al., 2018,
2019) and C-terminal (Huang et al., 2018, 2019; Wang et al.,
2018) ADPR-binding sites seem to be involved in channel acti-
vation, hampering functional dissection of nucleotide binding at
the two sites. Here, we exploited the enzymatic activity of
nvTRPM2 (Iordanov et al., 2019), and the functional indepen-
dence of its N- and C-terminal sites (Fig. 1; Kühn et al., 2016;
Iordanov et al., 2019), to selectively study for the first time nu-
cleotide binding at either site of a TRPM2 channel. We observed
marked differences between the affinity series for channel
activation/inhibition and for enzymatic activity (Fig. 2 and
Table 1). The nvNUDT9-H domain showed little selectivity
among the five tested nucleotides, with kcat values contained
within an approximately fivefold range (Fig. 2 H) and Km values
within an approximately sixfold range (Fig. 2 G and Table 1, left).
In contrast, the EC50 and IC50 values for channel activation/
inhibition by the same nucleotides spanned a range of >600-fold
(Fig. 2 D and Table 1, center column). Importantly, the two
affinity profiles were clearly uncorrelated, being characterized
by a sequence Br-ADPR≤ADPR≤dADPR<ADPRP≤ε-ADPR for
nvNUDT9-H, but by a sequence ADPRP<<ADPR≤dADPR<Br-
ADPR<<ε-ADPR for the activating site. These results provide a
first selective characterization of substrate specificities at the
NUDT9-H domain and the activating site, respectively, in a
TRPM2 channel.
On the other hand, the affinity series for channel acti-
vation by various ADPR analogues was markedly different
for nvTRPM2 relative to hsTRPM2. For instance, ADPRP which,
compared with ADPR, acts as a low-affinity partial agonist on
hsTRPM2 (Tóth et al., 2015) turned out to be the highest-affinity
agonist of nvTRPM2, with an EC50 for channel activation ap-
proximately fivefold lower than for ADPR (Fig. 2 D and Table 1).
Moreover, in earlier reports, two synthetic ADPR analogues
were shown to inhibit hsTRPM2 (Moreau et al., 2013) but acti-
vate nvTRPM2 (Kühn et al., 2019). This might raise the question
whether the activating ADPR-binding site in nvTRPM2 corre-
sponds to the same N-terminal site located in the vertebrate
TRPM2 structures, such as ADPR-bound drTRPM2 (PDB acces-
sion no. 6DRJ) and hsTRPM2 (PDB accession no. 6PUS). How-
ever, we show here that truncations of amino acid side chains
corresponding to those that coordinate ADPR in the N-terminal
Figure 4. PIP2 responses ofWT andMHR1/2 domainmutant nvTRPM2 channels. (A–G)Macroscopic inside-out patch currents activated by 3.2 mMADPR
(gray bars) + 125 µM Ca2+ (long black bars) in the absence or presence of added 2.5 or 25 µM dioctanoyl-PIP2 (short black bars) for WT (A), T143A (B), R271A (C),
T307A (D), R329A (E), T179A (F), and Y264A (G) nvTRPM2. (H) Fractional activation of WT and mutant nvTRPM2 channels by 2.5 and 25 µM PIP2 (color coding
follows construct labeling in A–G). Currents in 2.5 or 25 µM PIP2 were normalized to those obtained without added PIP2 in the same patch. Data represent
mean ± SEM from three or four independent experiments.
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site of vertebrate TRPM2 channels (Fig. 3) robustly affect the
sensitivity toward activation of nvTRPM2 channels by nucleo-
tides (Figs. 5 and 6), increasing EC50 by up to three orders of
magnitude. Moreover, the nucleotide affinity sequence of the six
mutants was the same regardless of whether ADPR or ADPRP
was used for channel activation (Figs. 5 H and 6 H). This suggests
that the mutations and the removal of the 29-hydroxyl group
from ADPR additively affect the free energy of ligand binding,
consistent with the drTRPM2 and hsTRPM2 structures in which
none of the targeted side chains interacts with the 29-hydroxyl
group of ADPR. These findings establish that the same
N-terminal ADPR-binding site observed in the MHR1/2 domain
of vertebrate TRPM2 channels was already present in ancient
cnidarians.
Our detailed characterization of the functional effects of the
six side-chain truncations provides the first insights into the
mechanistic contributions of those side chains to channel gating.
To draw such mechanistic inferences, one has to consider the
Figure 5. Apparent affinities for channel activation by ADPR of WT
nvTRPM2 and MHR1/2 domain mutants. (A–G) Macroscopic inside-out
patch currents of WT (A), T143A (B), R271A (C), T307A (D), R329A (E),
T179A (F), and Y264A (G) nvTRPM2 activated by increasing concentrations of
ADPR (gray bars) in the presence of 125 µM Ca2+ + 2.5 µM PIP2 (black bars).
(H) ADPR dose–response curves of fractional currents, normalized to the
mean of the currents observed during bracketing applications of saturating
ADPR in the same patch, for WT and mutant nvTRPM2 channels (color coding
follows construct labeling in A–G). Data represent mean ± SEM from 3 to 17
independent experiments. Colored lines are fits to the Hill equation yielding
fit parameters EC50 = 1.5 ± 0.1 µM and nH = 1.7 ± 0.2 for WT, EC50 = 6.3 ± 0.3
µM and nH = 2.6 ± 0.2 for T143A, EC50 = 0.62 ± 0.05 µM and nH = 1.4 ± 0.2 for
R271A, EC50 = 31 ± 2 µM and nH = 2.0 ± 0.2 for T307A, EC50 = 1,710 ± 934 µM
and nH = 1.3 ± 0.3 for R329A, EC50 = 14 ± 1 µM and nH = 1.9 ± 0.2 for T179A,
and EC50 = 1,867 ± 936 µM and nH = 1.4 ± 0.3 for Y264A nvTRPM2.
Figure 6. Apparent affinities for channel activation by ADPRP of WT
nvTRPM2 and MHR1/2 domain mutants. (A–G) Macroscopic inside-out
patch currents of WT (A), T143A (B), R271A (C), T307A (D), R329A (E),
T179A (F), and Y264A (G) nvTRPM2 activated by increasing concentrations of
ADPRP (gray bars) in the presence of 125 µM Ca2+ + 2.5 µM PIP2 (black bars).
(H) ADPRP dose–response curves of fractional currents, normalized to the
mean of the currents observed during bracketing applications of saturating
ADPRP in the same patch, for WT and mutant nvTRPM2 channels (color
coding follows construct labeling in A–G). Data represent mean ± SEM from 3
to 18 independent experiments. Colored lines are fits to the Hill equation
yielding fit parameters EC50 = 0.31 ± 0.02 µM and nH = 1.8 ± 0.2 forWT, EC50 =
1.5 ± 0.1 µM and nH = 1.8 ± 0.1 for T143A, EC50 = 0.089 ± 0.005 µM and nH =
1.7 ± 0.2 for R271A, EC50 = 12 ± 1 µM and nH = 1.6 ± 0.2 for T307A, EC50 = 121 ±
7 µM and nH = 2.1 ± 0.2 for R329A, EC50 = 3.9 ± 0.5 µM and nH = 1.4 ± 0.2 for
T179A, and EC50 = 85 ± 8 µM and nH = 1.8 ± 0.3 for Y264A nvTRPM2.
Tóth et al. Journal of General Physiology 9 of 12
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relationship between measured EC50 values for ligand activation
and the actual ligand-binding affinities (Kd) for the activating
site. By the principle of microscopic reversibility, an activating
ligand binds more tightly to the open state than to the closed
state, and the EC50 for channel activation is a weighted average
of the closed- and open-state affinities. For example, for a
channel with a single ligand-binding site,
EC50 Kcd · (1 − Po;max) + Kod · Po;max, (1)
where Kcd and K
o
d are the ligand dissociation constants of the
closed and open channels (Kcd >K
o
d) and Po;max is the Po of a
ligand-bound channel. At the same time, the ratio Kcd/K
o
d pro-
vides the efficacy of the ligand, i.e., the fold increase in the







where ξmin and ξmax are the closed–open equilibrium constants
of unliganded and liganded channels.
Mutation of three side chains involved in adenine or
α-phosphate coordination in the N-terminal site (Fig. 3) reduced
Po in 3.2 mM ADPR, as reported by robust responses to 2.5 and
25 µM exogenous PIP2 (Fig. 4, E–H, purple, light blue, and yellow
symbols). Because for the T179A mutant 3.2 mM ADPR clearly
represents a saturating concentration (Fig. 5 H, light blue sym-
bols), for this mutant, Po of fully liganded channels (Po;max) is
clearly dramatically reduced (Po;max less than ∼0.0125 without
added PIP2). Although for the R329A and Y264Amutants 3.2 mM
ADPR failed to saturate the channels (Fig. 5 H, purple and yellow
symbols), tentative fits to the dose–response curves (Fig. 5 H,
purple and yellow solid lines) suggested maximal Po values only
∼1.5-fold higher than those in 3.2 mM ADPR. Given that for
these two mutants exposure to 25 µM PIP2 could stimulate Po in
3.2 mM ADPR by ∼6-fold and ∼40-fold, respectively (Fig. 4 H,
purple and yellow symbols), our upper estimates of Po;max are
∼0.25 for R329A and ∼0.038 for Y264A. Thus, these three mu-
tations reduce maximal Po of nvTRPM2 channels, but at the
same time, they also dramatically reduce ADPR-binding affinity
(Fig. 4, E–H; Fig. 5, E–H; and Fig. 6, E–H, purple, light blue, and
yellow symbols). These findings suggest that the T179, R329, and
Y264 side chains play important roles not only in ligand binding
per se, but also in ligand-induced conformational changes:
i.e., their interactions with the bound nucleotide become stron-
ger in the open-channel conformation. As a consequence, upon
truncation of these side chains, Kod increases more dramatically
than Kcd, causing, in addition to an increased EC50 (see Eq. 1), a
smaller fractional increase in the closed–open equilibrium con-
stant upon ligand binding (see Eq. 2).
In contrast, truncation of the T307 and T143 side chains, in-
volved in contacting the β phosphate and the terminal ribose,
respectively (Fig. 3), did not reduce maximal Po, as signaled by
no further stimulation by exogenous PIP2 (Fig. 4, B, D and H,
dark blue and red symbols) but selectively impaired binding
affinity (Fig. 5, B and H; and Fig. 6, B, D and H, dark blue and red
symbols). Thus, these contacts substantially contribute to ligand
binding, but the strength of the interactions seems little affected
by channel opening/closure. As a consequence, truncation of
these side chains similarly increases Kod and K
c
d, yielding an in-
creased EC50 (see Eq. 1) but leaving the efficacy of the ligand
unaffected (see Eq. 2).
A stabilizing interaction between the terminal ribose of
ADPR and the side chain of the arginine corresponding to R278
Figure 7. Apparent affinities for channel activation by Ca2+ of WT
nvTRPM2 and MHR1/2 domain mutants. (A–G) Macroscopic inside-out
patch currents of WT (A), T143A (B), R271A (C), T307A (D), R329A (E),
T179A (F), and Y264A (G) nvTRPM2 activated by increasing concentrations of
Ca2+ (gray bars) in the presence of saturating ADPRP + 2.5 µM PIP2 (black
bars). [ADPRP] is 10 µM in A and C, 100 µM in B and F, and 1,000 µM in D, E,
and G. (H) Ca2+ dose–response curves of fractional Pos, normalized to the
mean of the Pos during bracketing applications of 125 µM Ca2+ in the same
patch, for WT and mutant nvTRPM2 channels (color coding follows construct
labeling in A–G). Fractional Pos (Po/Po;125Ca2+) were obtained by dividing
fractional macroscopic current in test [Ca2+] (I/I125Ca2+; Fig. S2 A) by fractional
unitary current at the same [Ca2+] (i/i125Ca2+; cf. Fig. S2 B). Data represent
mean ± SEM from 5 to 10 independent experiments. Colored lines are fits to
the Hill equation yielding fit parameters EC50 = 0.88 ± 0.07 µM and nH = 1.7 ±
0.2 for WT, EC50 = 0.64 ± 0.02 µM and nH = 2.3 ± 0.2 for T143A, EC50 = 1.68 ±
0.04 µM and nH = 3.0 ± 0.2 for R271A, EC50 = 0.93 ± 0.05 µM and nH = 1.9 ± 0.2
for T307A, EC50 = 1.1 ± 0.04 µM and nH = 2.0 ± 0.2 for R329A, EC50 = 1.8 ± 0.1
µM and nH = 2.3 ± 0.1 for T179A, and EC50 = 2.0 ± 0.1 µM and nH = 1.8 ± 0.1 for
Y264A nvTRPM2.
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in nvTRPM2 is observed both in the drTRPM2 (Fig. 3 B) and
hsTRPM2 structures, and truncation of this side chain reduced
macroscopic currents for the vertebrate channels (Huang et al.,
2018, 2019). Based on those reports, the slight leftward shift in
the ADPR and ADPRP dose–response curves of R271A nvTRPM2
channels (Fig. 5, C and H; and Fig. 6, C and H, green symbols)
was unexpected. At the same time, the modest stimulation of
this mutant by exogenous PIP2 (Fig. 4, C and H, green symbols)
signals an approximately twofold reduction in maximal Po. Al-
though in the absence of a high-resolution structure of an ADPR-
bound nvTRPM2 N-terminal site we can only speculate on the
mechanism of these findings, the simplest explanation for this
complex phenotype is a selective decrease in Kcd in the mutant:
together with a decrease in EC50 (see Eq. 1), such a change would
also predict a reduced maximal efficacy for the ligands (see
Eq. 2), as observed. For example, using the simplistic single
binding site model, the set of parameters Kcd  7 μM,
Kod  0.007 μM, and Po;min = 0.004 for WT nvTRPM2 predicts
observable parameters Po;max = 0.8 and EC50 = 1.4 µM, as ob-
served with ADPR as the activating ligand (Fig. 5 H, black
symbols). Relative to this situation, an isolated sixfold decrease
in Kcd to K
c
d  1.17 μM results in observable parameters Po;max =
0.4 and EC50 = 0.7 µM, consistent with our observations on
nvTRPM2-R271A (Fig. 5 H, green symbols). Such a scenario
would suggest that in WT nvTRPM2, the R271 side chain in-
terferes with ADPR binding in the closed, but not open, state.
Validation of that assumption would require an atomic
nvTRPM2 structure in which the N-terminal site is ligand
bound, but its conformation corresponds to that in the closed-
channel state.
In principle, a mutation-induced shift in the apparent af-
finity for channel activation by a ligand does not necessarily
prove that the targeted region forms a binding site for that
ligand. Based on Eq. 1, any mutation that reduces Po;max will
necessarily increase EC50 for the activating ligand by shifting
the equilibrium toward the closed states, which bind the
ligand less tightly. For that reason, in TRPM2, which is co-
activated by two types of ligand, ADPR and Ca2+, mutations in
either of the two ligand-binding sites might increase EC50
even for the other ligand. For example, a mutation in the Ca2+-
binding site that reduces the Ca2+ affinity of the channels to
an extent that 125 µM Ca2+ is no longer saturating will reduce
Po;max for ADPR when assayed in 125 µM Ca2+ and therefore
also increase EC50 for ADPR activation. Indeed, a previous
study suggested that the region targeted by our mutations
forms a Ca2+-binding site (Luo et al., 2018b). To exclude that
such a mechanism underlies the up to three orders of mag-
nitude shifts in EC50 for ADPR or ADPRP activation caused by
our mutations (Figs. 5 H and 6 H), we assessed the EC50 for
Ca2+ activation of the same constructs under conditions in
which Po;max remains high even for the mutant channels (in
saturating ADPRP plus 2.5 µM PIP2). Under such conditions,
EC50 for Ca2+ activation remained within twofold of WT for all
mutants (Fig. 7 H), precluding involvement of the target re-
gion in the formation of a Ca2+-binding site and consistent
with structural (Zhang et al., 2018; Huang et al., 2018, 2019) and
functional (Zhang et al., 2018) studies that have unanimously
pinpointed the latter to be located within the transmembrane
domain.
In conclusion, we have shown that in an ancient cnidarian
TRPM2 channel the same N-terminal ADPR-binding site ob-
served in vertebrate channel structures is already present and
that the N- and C-terminal binding sites are functionally inde-
pendent. We have selectively measured nucleotide affinity
profiles at those two sites and provided first insights into the
mechanistic contributions to channel gating of conserved amino
acid side chains that line the N-terminal site. Further work will be
needed to similarly elucidate the specific properties, and func-
tional contributions to channel gating, of the N- and C-terminal
sites in vertebrate TRPM2 channels.
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Supplemental material
Figure S1. Deletion of nvNUDT9-H coding sequence results in channels indistinguishable from nvTRPM2(1208STOP). (A) Macroscopic current acti-
vated by cytosolic exposure to increasing concentrations of ADPR (gray bars) plus 125 µM Ca2+ (black bar), recorded from an inside-out patch excised from a
Xenopus oocyte preinjected with cRNA encoding nvTRPM2(1208CUT). (B) Steady-state currents in the presence of test [ADPR], normalized to the mean of the
currents during bracketing exposures of the same patch to 320 µM ADPR, plotted as a function of [ADPR] (orange symbols). Data represent mean ± SEM from 5
to 12 independent experiments. Fits to the Hill equation (colored lines) yielded fit parameters of EC50 = 4.6 ± 0.3 µM and nH = 1.7 ± 0.2. Red (1208STOP) and
dark blue (full-length) symbols replot data from Fig. 1 D for comparison.
Figure S2. Correction for pore block by cytosolic Ca2+, for obtaining apparent affinities for channel activation by Ca2+ of WT nvTRPM2 and MHR1/
2 domain mutants. (A) Ca2+ dose–response curves of macroscopic currents from Fig. 7, A–G, normalized to the mean of the currents during bracketing
applications of 125 µM Ca2+ in the same patch (I/I125Ca2+), for WT and mutant nvTRPM2 channels (color coding follows construct labeling in Fig. 7, A–G). Data
represent mean ± SEM from 5 to 10 independent experiments. Colored lines are fits to the Hill equation. (B) Unitary nvTRPM2 current amplitudes (i) at −20 mV
in our recording solutions (see Materials and methods), with cytosolic (bath) Ca2+ concentrations indicated below each bar. Data represent mean ± SEM from 3
to 14 independent experiments. The Po/Po;125Ca2+ symbols in Fig. 7 H were obtained as (I/I125Ca2+)/(i/i125Ca2+).
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